BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 29, 2000
View Archived Issues
NeoRx's myeloma therapy shows excellent phase II safety results
Read More
La Jolla Pharmaceutical updates progress with lupus drug
Read More
Vical, Human Genome Sciences and Vascular Genetics form collaboration
Read More
Angiotech announces promising results from phase I/II SPMS study
Read More
Unigene achieves milestone in osteoporosis collaboration
Read More
Micardis enters large-scale efficacy trial
Read More
Oxford GlycoSciences highlights principal achievements for 1999
Read More
Medco shareholders approve merger with King Pharmaceuticals
Read More
Selective rotamase inhibitors described by Pfizer for neurological disorders
Read More
Zambon presents new PDE4 inhibitors useful for respiratory diseases
Read More
Hepatitis C product candidate enters phase I testing in U.K.
Read More
New cardiovascular/renal agents under study at SmithKline Beecham
Read More
Tulane team studies gene therapy for pulmonary hypertension
Read More
Bioprojet claims new, orally active histamine H3 antagonists
Read More
Wound-healing gene therapy using NAB2
Read More
New series from American Cyanamid inhibits angiogenesis by targeting VEGF
Read More
Joint effort by OSI, Wyeth-Ayerst results in identification of novel calcitonin-inducing agents
Read More
AdProTech's APT-070 shows encouraging preclinical results in transplantation
Read More
5-HT2C receptor inverse agonists selected for further study in CNS disorders
Read More
Lorus's lead anticancer products reduce tumor growth in mouse models of prostate cancer
Read More
Nycomed Amersham receives approvable letter for extended use of Myoview
Read More
IRB approval received to commence phase II trial of GBC-590
Read More
Abgenix extends antibody collaboration with Pfizer
Read More
Searle identifies novel series of LTA4 hydrolase inhibitors, some with good oral activity
Read More
Safety and efficacy of seocalcitol examined in phase II colorectal cancer study
Read More
Positive early clinical results for decitabine in advanced NSCLC
Read More
Monoclonal antibody targeting Lewis X combined with chemotherapy in breast cancer
Read More